Arbutus Reports First Quarter 2020 Financial Results, Provides Pipeline Update and Announces New Research Initiative to Identify Novel Antiviral Therapies for the Treatment of Coronavirus Infections
Go back to Arbutus Reports First Quarter 2020 Financial Results, Provides Pipeline Update and Announces New Research Initiative to Identify Novel Antiviral Therapies for the Treatment of Coronavirus Infections| (NASDAQ: ABUS) | Delayed: 5.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.00 | 52 Week High | $5.88 | |||
| Open | $5.00 | 52 Week Low | $2.65 | |||
| Day High | $5.00 | P/E | N/A | |||
| Day Low | $5.00 | EPS | $0.00 | |||
| Volume | 195 | |||||
| (NASDAQ: ABUS) | Delayed: 5.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.00 | 52 Week High | $5.88 | |||
| Open | $5.00 | 52 Week Low | $2.65 | |||
| Day High | $5.00 | P/E | N/A | |||
| Day Low | $5.00 | EPS | $0.00 | |||
| Volume | 195 | |||||
